These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32374601)

  • 1. Structural Fingerprints of an Intact Monoclonal Antibody Acquired under Formulated Storage Conditions via
    Tokunaga Y; Takeuchi K; Okude J; Ori K; Torizawa T; Shimada I
    J Med Chem; 2020 May; 63(10):5360-5366. PubMed ID: 32374601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of NMR in High Ordered Structure Characterization of Monoclonal Antibodies.
    Tokunaga Y; Takeuchi K
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling formulated monoclonal antibodies by (1)H NMR spectroscopy.
    Poppe L; Jordan JB; Lawson K; Jerums M; Apostol I; Schnier PD
    Anal Chem; 2013 Oct; 85(20):9623-9. PubMed ID: 24006877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR spectroscopy as a characterization tool enabling biologics formulation development.
    Ma J; Pathirana C; Liu DQ; Miller SA
    J Pharm Biomed Anal; 2023 Jan; 223():115110. PubMed ID: 36308923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study.
    Grinstead JS; Schuman JT; Campbell AP
    Biochemistry; 2003 Dec; 42(48):14293-305. PubMed ID: 14640698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing monoclonal antibody formulations in arginine glutamate solutions using
    Kheddo P; Cliff MJ; Uddin S; van der Walle CF; Golovanov AP
    MAbs; 2016 Oct; 8(7):1245-1258. PubMed ID: 27589351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target-specific NMR detection of protein-ligand interactions with antibody-relayed
    Hetényi A; Hegedűs Z; Fajka-Boja R; Monostori É; Kövér KE; Martinek TA
    J Biomol NMR; 2016 Dec; 66(4):227-232. PubMed ID: 27885546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics.
    Brinson RG; Marino JP; Delaglio F; Arbogast LW; Evans RM; Kearsley A; Gingras G; Ghasriani H; Aubin Y; Pierens GK; Jia X; Mobli M; Grant HG; Keizer DW; Schweimer K; Ståhle J; Widmalm G; Zartler ER; Lawrence CW; Reardon PN; Cort JR; Xu P; Ni F; Yanaka S; Kato K; Parnham SR; Tsao D; Blomgren A; Rundlöf T; Trieloff N; Schmieder P; Ross A; Skidmore K; Chen K; Keire D; Freedberg DI; Suter-Stahel T; Wider G; Ilc G; Plavec J; Bradley SA; Baldisseri DM; Sforça ML; Zeri ACM; Wei JY; Szabo CM; Amezcua CA; Jordan JB; Wikström M
    MAbs; 2019 Jan; 11(1):94-105. PubMed ID: 30570405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A set of 4D NMR experiments of enhanced resolution for easy resonance assignment in proteins.
    Zawadzka-Kazimierczuk A; Kazimierczuk K; Koźmiński W
    J Magn Reson; 2010 Jan; 202(1):109-16. PubMed ID: 19880336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping monoclonal antibody structure by 2D 13C NMR at natural abundance.
    Arbogast LW; Brinson RG; Marino JP
    Anal Chem; 2015 Apr; 87(7):3556-61. PubMed ID: 25728213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies.
    Majumder S; Jones MT; Kimmel M; Alphonse Ignatius A
    Pharm Res; 2018 Sep; 35(11):220. PubMed ID: 30255351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 13C NMR study of the hinge region of a mouse monoclonal antibody.
    Matsunaga C; Kato K; Arata Y
    J Biomol NMR; 1991 Nov; 1(4):379-90. PubMed ID: 1841706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-State NMR Characterization of Lyophilized Formulations of Monoclonal Antibody Therapeutics.
    Perodeau J; Arbogast LW; Nieuwkoop AJ
    Mol Pharm; 2023 Mar; 20(3):1480-1489. PubMed ID: 36702622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen-deuterium (H/D) exchange mapping of Abeta 1-40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy.
    Whittemore NA; Mishra R; Kheterpal I; Williams AD; Wetzel R; Serpersu EH
    Biochemistry; 2005 Mar; 44(11):4434-41. PubMed ID: 15766273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assignment of backbone (1)H, (13)C and (15)N resonances of human IgG1 Fc (51.4 kDa).
    Liu D; Cocco MJ; Rosenfied R; Lewis JK; Ren D; Li L; Remmele RL; Brems DN
    Biomol NMR Assign; 2007 Dec; 1(2):233-5. PubMed ID: 19636873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High throughput peptide mapping method for analysis of site specific monoclonal antibody oxidation.
    Li X; Xu W; Wang Y; Zhao J; Liu YH; Richardson D; Li H; Shameem M; Yang X
    J Chromatogr A; 2016 Aug; 1460():51-60. PubMed ID: 27432793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platform development for expression and purification of stable isotope labeled monoclonal antibodies in Escherichia coli.
    Reddy PT; Brinson RG; Hoopes JT; McClung C; Ke N; Kashi L; Berkmen M; Kelman Z
    MAbs; 2018 Oct; 10(7):992-1002. PubMed ID: 30060704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR-based metabolite studies with
    Ramirez B; Durst MA; Lavie A; Caffrey M
    Sci Rep; 2019 Sep; 9(1):12798. PubMed ID: 31488858
    [No Abstract]   [Full Text] [Related]  

  • 19. Utilization of site-directed spin labeling and high-resolution heteronuclear nuclear magnetic resonance for global fold determination of large proteins with limited nuclear overhauser effect data.
    Battiste JL; Wagner G
    Biochemistry; 2000 May; 39(18):5355-65. PubMed ID: 10820006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TROSY and CRINEPT: NMR with large molecular and supramolecular structures in solution.
    Riek R; Pervushin K; Wüthrich K
    Trends Biochem Sci; 2000 Oct; 25(10):462-8. PubMed ID: 11050425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.